Skip to main content
. Author manuscript; available in PMC: 2022 Jan 6.
Published in final edited form as: Clin Transl Oncol. 2021 Aug 9;24(1):127–144. doi: 10.1007/s12094-021-02677-8

Table 1.

Relative abundance of human-specific and mouse-specific genes present in lower passage (T1) and higher passage (T4) tumors compared to the original TU-BcX-4IC specimen (T0). Percentages are shown in relation to the total genome analyzed with RNA sequencing

T0 T1 T4
Human specific 23% 27.5% 43%
Mouse specific 0.03% 0.75% 0.87%